Fundz

Evofem Biosciences reported raising $1.38 Million in an initial SEC Form D filing, from an offering of $1.38 Million

PUBLIC · EVFMMar 06, 2023

Amount Raised

$1.38 Million

$1.38 Million sold, per SEC Form D (first sale Feb 17, 2023)

Round Type

Seed

San DiegoBiotechnology

Quick answer

Evofem Biosciences raised $1.38 Million in a Seed round, dated February 17, 2023. Evofem Biosciences is based in San Diego, California, United States.

How much did Evofem Biosciences raise?
Evofem Biosciences raised $1.38 Million in a Seed round on February 17, 2023.
What does Evofem Biosciences do?
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.
Where is Evofem Biosciences based and how big is it?
Evofem Biosciences is based in San Diego, California, United States.
Who are the decision-makers at Evofem Biosciences?
Fundz holds 1 contact at Evofem Biosciences, including the Global Distribution. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Evofem Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Aduro Clean Technologies raised $519K (Seed) on April 3, 2023.
  • ClinOne, Inc. raised $11M on April 3, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on April 3, 2023.
  • Greentank Technologies raised $17M (Series B) on April 3, 2023.
  • PureIMS raised an undisclosed amount on April 3, 2023.
  • OUROTECH, INC.- PEAR BIO raised $14M on April 3, 2023.

Who to call at Evofem Biosciences, and when

A new round usually means Evofem Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Evofem Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evofem Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evofem Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evofem Biosciences

Location

12400 HIGH BLUFF DRIVE, SUITE 600

San Diego, California, United States

About

Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex. In July 2024, Evofem acquired SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evofem Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSaundra P., Global Distribution hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Evofem Biosciences's next move

See what Strategic adds

Evofem Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.